Intersect ENT drums up $30 million

November 1, 2010 by MassDevice staff

Intersect ENT Inc. closes a $30 million round of financing to commercialize its first product, a stent-based treatment for sinusitus.

Intersect ENT logo

Intersect ENT Inc. completed a $30 million funding round, the company said.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.